203
Participants
Start Date
August 29, 2022
Primary Completion Date
May 10, 2024
Study Completion Date
May 10, 2024
Temelimab 54mg/kg
Temelimab 54mg/kg will be given as monthly (every 4 weeks) intravenous (IV) infusion over 24 weeks (6 infusions in total)
Placebo
Placebo will be given as monthly (every 4 weeks) intravenous (IV) infusion over 24 weeks (6 infusions in total)
Inselspital Bern University Hospital Bern, Bern
Geneva University Hospital, Geneva
Centre hospitalier du Valais Romand (CHVR) - Hôpital du Valais, Sion
REHAB Clinic for Neurorehabilitation and Paraplegiology, Basel
Kantonsspital Graubünden, Chur
Private clinic Blue Healthcare, Madrid
Hospital Universitario Quirónsalud Madrid, Madrid
Hospital of Vipiteno, Sterzing
Clinica Metabolica dell'Università di Modena e Reggio Emilia, Modena
Hospital General Universitario- Servicio de Medicina Interna, Valencia
Hospital Royo Villanova, Zaragoza
U.O.C. Malattie Infettive Tor Vergata, Policlincio Tor Vergata, Roma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma
Ace Alzheimer Center, Barcelona
Lead Sponsor
GeNeuro SA
INDUSTRY